What Is Mast Cell Activation Syndrome?
Mast Cell Activation Syndrome (MCAS) is a condition where mast cells in the body release too many chemicals too frequently, causing various symptoms. Mast cells are immune system cells found throughout the body—in the skin, lungs, gut, and other tissues. Their job is to release chemicals like histamine when they detect a threat, such as an allergen or pathogen. In people with MCAS, these cells release chemicals even when there is no real threat, or they release excessive amounts of chemicals in response to normal triggers.
Free Guide to Marriage License Costs by State →
The symptoms of MCAS can appear suddenly and vary widely from person to person. Common symptoms include flushing, itching, hives, abdominal pain, diarrhea, nausea, low blood pressure, rapid heart rate, headaches, and breathing difficulties. Some people experience symptoms in one body system, while others have symptoms across multiple systems. Symptoms may last minutes to hours and can change day to day or even throughout the same day.
MCAS differs from other conditions because it involves abnormal behavior of mast cells rather than abnormal numbers of mast cells. This distinction matters for testing and diagnosis. MCAS is sometimes confused with mast cell leukemia or mastocytosis, which are different diseases involving actual increases in mast cell count. Understanding this difference helps explain why certain tests are used to diagnose MCAS while others rule out related conditions.
Researchers estimate that MCAS affects between 0.01% and 1% of the population, though some experts believe it may be underdiagnosed. The condition can develop at any age, from childhood to adulthood. Some people report that their symptoms began after a viral infection, physical trauma, or emotional stress, though the exact cause of MCAS remains unclear.
Takeaway: MCAS involves mast cells releasing too many chemicals too often, causing a range of symptoms that can affect different body systems. Recognizing these patterns helps explain why specific testing approaches are used to identify the condition.
Understanding the Role of Histamine and Tryptase in Testing
Histamine is the primary chemical released by mast cells, and it plays a central role in MCAS testing. When mast cells activate, they release histamine into surrounding tissues and into the bloodstream. Histamine causes many of the symptoms people with MCAS experience—flushing, itching, swelling, and abdominal cramping result directly from histamine activity. Blood tests measure histamine levels, but timing is critical because histamine breaks down quickly in the bloodstream, usually within 15 minutes. This short window means blood must be collected during or immediately after a symptom flare to detect elevated histamine.
Get Your Free Spruce Power Bill Payment Guide →
Tryptase is an enzyme released by mast cells alongside histamine. Unlike histamine, tryptase breaks down much more slowly in the bloodstream, making it easier to measure. There are two types of tryptase measurements: baseline tryptase (measured when symptoms are not occurring) and acute tryptase (measured during a symptom flare). A single baseline tryptase level does not diagnose MCAS on its own, but persistently elevated baseline tryptase (typically above 11.5 ng/mL) suggests mast cell disease and may warrant further investigation. When tryptase rises significantly during a symptom episode compared to baseline, this can support an MCAS diagnosis.
Medical professionals typically look at the relationship between baseline and acute tryptase levels. An increase of 1.2 times or more above baseline during symptoms, or an acute level above 11.5 ng/mL, can be meaningful. However, a normal tryptase level does not rule out MCAS, because roughly 30-50% of people with MCAS have normal or only mildly elevated tryptase levels. This is why MCAS diagnosis relies on multiple types of information rather than a single test result.
Other chemicals released by mast cells that may be measured include heparin, chymase, and chromogranin A. Each provides different information about mast cell behavior. Heparin and chymase are stored in mast cell granules and released during activation. Chromogranin A is a marker of neuroendocrine activation and may reflect overall neuroendocrine system involvement in MCAS symptoms.
Takeaway: Histamine and tryptase measurements form the backbone of MCAS testing, but each has limitations. Histamine requires perfect timing during symptoms, while tryptase may be normal even in people with MCAS, so testing should include multiple markers and clinical information.
Common Laboratory Tests for MCAS Diagnosis
The foundation of MCAS diagnosis involves measuring mast cell mediators—the chemicals released during activation. Blood tests for serum tryptase represent the most widely available test. During a routine office visit or when symptoms are not present, a baseline tryptase level is obtained. If symptoms are occurring at the time of testing, acute tryptase should also be measured. Laboratories typically report reference ranges, with values above 11.5 ng/mL considered elevated. Some laboratories use slightly different cutoff values, so results should be interpreted in context of the specific lab's reference range.
Learn About Dental Implants in Cherryville →
Twenty-four-hour urine collection is another common test for MCAS evaluation. During this test, all urine produced over 24 hours is collected in a special container. The urine is then analyzed for histamine metabolites, particularly N-methylhistamine, which reflects histamine release over the full day rather than just at a single moment. This test provides information about total histamine burden and can sometimes be abnormal even when blood histamine is normal. Urine histamine metabolite testing may be ordered multiple times—both during symptomatic periods and when symptoms are controlled—to assess baseline versus flare-state levels.
Plasma histamine testing requires special collection procedures. Blood must be drawn into specific tubes containing preservatives and must be kept on ice immediately after collection. The sample must reach the laboratory quickly and be processed within a very short timeframe. Because of these demanding requirements, many hospitals and routine laboratories cannot perform this test. If ordered, patients should confirm collection procedures with their medical provider and the specific laboratory that will process the sample.
Bone marrow biopsy is occasionally performed when other testing results are unclear or when distinguishing MCAS from mastocytosis is necessary. This procedure involves taking a small sample of bone marrow, typically from the hip bone, and examining it under a microscope for mast cell characteristics. Bone marrow biopsy can show whether mast cell numbers are abnormally high (suggesting mastocytosis) or normal (consistent with MCAS). While bone marrow biopsy is more invasive than blood or urine testing, it provides definitive information about mast cell morphology and can include genetic testing for specific mutations associated with mast cell disease.
Takeaway: MCAS testing typically begins with serum tryptase and urine histamine metabolite testing, with plasma histamine testing and bone marrow biopsy reserved for situations requiring more definitive information about mast cell behavior and structure.
What Testing Cannot Do and Why Alternative Diagnoses Matter
No single test confirms or rules out MCAS with absolute certainty. Even when multiple tests show abnormal results, diagnosis requires correlation with clinical symptoms and exclusion of other conditions that produce similar symptoms. This is why the diagnostic process for MCAS involves careful evaluation by a healthcare provider rather than reliance on test results alone. Some people with abnormal mediator test results may have another condition entirely, while some people with normal test results may still have MCAS if clinical symptoms are consistent and other diagnoses have been excluded.
Learn About Paying Your Aspire Insurance Bill →
Many conditions mimic MCAS symptoms. Hyperthyroidism causes flushing, rapid heart rate, and anxiety. Pheochromocytoma, a rare adrenal gland tumor, causes sudden episodes of flushing, sweating, and elevated heart rate. Carcinoid syndrome results from tumors releasing serotonin and other chemicals, causing flushing and diarrhea. Medication side effects, particularly from NSAIDs or certain blood pressure medications, can trigger histamine release through mechanisms distinct from MCAS. Anxiety disorders and panic attacks produce symptoms that closely resemble acute mast cell activation. Gastrointestinal infections cause abdominal pain, diarrhea, and nausea similar to GI-predominant MCAS.
Because symptom overlap is so extensive, testing for alternative diagnoses is